Diurnal variability—time to change asthma guidelines?

BMJ

Volumn 319, Issue 7201, 1999, Pages 45-

  Reddel, Helen ^a   Jenkins, Christine ^a   Woolcock, Ann ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; CIRCADIAN RHYTHM; DRUG ADMINISTRATION; HUMAN; LUNG; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; AIRWAY DYNAMICS; CLINICAL PRACTICE; DISEASE CONTROL; DISEASE SEVERITY; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SHORT SURVEY;

ASTHMA; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; HUMANS; LUNG; PEAK EXPIRATORY FLOW RATE; PRACTICE GUIDELINES;

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT;

EID: 0033519804     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.319.7201.45     Document Type: Article

References (33)

1. Hetzel Mr, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732–738.
2. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma expert panel. Report 2. Bethesda, MD: National Institutes of Health, 1997 (NIH publication No 97-4051, NHLBI.)
3. British Thoracic Society, National Asthma Campaign and Royal College of Physicians of London in association with the General Practitioner in Asthma Group, British Association of Accident and Emergency Medicine, British Paediatric Respiratory Society, Royal College of Paediatric and Child Health. The British guidelines on asthma management. 1995 review and position statement. Thorax 1996; 52(suppl 1): S1–21.
4. Global Initiative for Asthma. In: Global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, 1995 (NIH publication No 96-3659A, NHLBI.)
5. National Heart Lung and Blood Institute. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992; 22(suppl 1): 1–72.
6. Newhouse MT The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990; 85: 1098–1111.
7. National Asthma Campaign [Australia]. Asthma management handbook. Melbourne: National Asthma Campaign, 1998.
8. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423–429.
9. Neukirch F, Liard R, Segala C, Korobaeff M, Henry C, Cooreman J. Peak expiratory flow variability and bronchial responsiveness to methacholine. Am Rev Respir Dis 1992; 146: 71–75.
10. Lebowitz MD, Krzyzanowski M, Quackenboss JJ, O'Rourke MK. Diurnal variation of PEF and its use in epidemiological studies. Eur Respir J 1997; 10(suppl 24): 49–56s.
11. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PGJ, Tattersfield AE. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis 1992; 145: 588–593.
12. Toogood JH, Andreaou P, Baskerville J. A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations. J Allergy Clin Immunol 1996; 98: 555–562.
13. Connolly CK. The effect of bronchodilators on diurnal rhythms in airway obstruction. Br J Dis Chest 1981; 75: 197–203.
14. Gannon PFG, Newton DT, Pantin CFA, Burge PS. Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation. Thorax 1998; 53: 790–792.
15. D'Alonzo GE, Volker WS, Keller A. Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma. Am J Resp Crit Care Med 1995; 152: 1097–1099.
16. Côté J, Cartier A, Malo J-L, Rouleau M, Boulet L-P. Compliance with peak expiratory flow monitoring in home management of asthma. Chest 1998; 113: 968–972.
17. Higgins BG, Britton JR, Chinn S, Jones TD, Jenkinson D, Burney PGJ, The distribution of peak flow variability in a population sample. Am Rev Respir Dis 1989; 140: 1368–1372.
18. Clark THJ, Hetzel Mr. Diurnal variation of asthma. Br J Dis Chest 1977; 71: 87–92.
19. Reddel HK, Ware SI, Salome CM, Jenkins CR, Woolcock AJ. Pitfalls in processing electronic spirometric data in asthma. Eur Respir J 1998; 12: 853–858.
20. Reddel HK, Ware SI, Salome CM, Marks GB, Jenkins CR, Woolcock AJ. Standardization of ambulatory peak flow monitoring: the importance of recent beta 2-agonist inhalation. Eur Respir J 1998; 12: 309–314.
21. Salome C, Reddel H, Ware S, Jenkins C, Woolcock A. Diurnal variability from twice daily PEF is unreliable for assessment of asthma severity. Am J Resp Crit Care Med 1998; 157: A631.
22. Dahl R, Earnshaw JS, Palmer JB. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4: 1178–1184.
23. Reddel HK, Ware SI, Marks GB, Salome CM, Jenkins CR, Woolcock AJ. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353: 364–369.
24. Siersted HC, Hansen HS, Hansen N-CG, Hyldebrandt N, Mostgaard G, Oxhoj H. Evaluation of peak expiratory flow variability in an adolescent population sample. The Odense schoolchild study. Am J Resp Crit Care Med 1994; 149: 598–603.
25. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest 1977; 71: 73–86.
26. Cross D, Nelson HS. The role of the peak flow meter in the diagnosis and management of asthma. J Allergy Clin Immunol 1991; 87: 120–128.
27. Brand PL, Duiverman EJ, Postma DS, Waalkens HJ, Kerrebijn KF, Van Essen-Zandvliet EE. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Eur Respir J 1997; 10: 1242–1247.
28. Côté J, Kennedy S, Chan-Yeung M. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 1993; 48: 48–51.
29. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Resp Crit Care Med 1995; 151: 1320–1325.
30. Connolly C, Prescott R, Alcock S, Gatnash A. Actual over best function as an outcome measure in asthma. Respir Med 1994; 88: 453–459.
31. Meijer RJ, Kerstjens HAM, Postma DS. Comparison of guidelines and self-management plans in asthma. Eur Respir J 1997; 10: 1163–1172.
32. Fishwick D, Beasley R. Use of peak-flow based self-management plans by adult asthmatic patients. Eur Respir J 1996; 9: 861–865.
33. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998; 317: 858–861.